Virology: Antiviral activity of anaferon (Pediatric formulation) in mice infected with pandemic infl uenza virus a(H1N1/09)

Bulletin of Experimental Biology and Medicine

Volumn 149, Issue 5, 2010, Pages 612-614

  Shishkina, L N ^a   Skarnovich, M O ^a   Kabanov, A S ^a   Sergeev, A A ^a   Olkin, S E ^a   Tarasov, S A ^b   Belopolskaya, M V ^b   Sergeeva, S A ^b   Epstein, O I ^b   Malkova, E M ^a   Stavsky, E A ^a   Drozdov, I G ^a  

^a STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY VECTOR   (Russian Federation)

^b Res and Prod Company Polyplastic   (Russian Federation)

Author keywords

Anaferon (pediatric formulation); Antiviral drugs; Influenza virus; Oseltamivir; Tamiflu

Indexed keywords

ANAFERON; ANTIVIRUS AGENT; OSELTAMIVIR; UNCLASSIFIED DRUG; WATER; ANTIBODY;

2009 H1N1 INFLUENZA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; INFLUENZA VIRUS A H1N1; MOUSE; NONHUMAN; TREATMENT OUTCOME; VIRUS LOAD; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECT; LUNG; ORTHOMYXOVIRUS INFECTION; VIROLOGY;

MUS; ORTHOMYXOVIRIDAE;

ANIMALS; ANTIBODIES; ANTIVIRAL AGENTS; INFLUENZA A VIRUS, H1N1 SUBTYPE; LUNG; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; OSELTAMIVIR;

EID: 79951641264     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-010-1006-0     Document Type: Article

References (5)

1. J. Dotis and E. Roilides, Hippokratia, 13, No. 3, 135-138 (2009).
2. R. Jain and R. D. Goldman, Pediatr. Emerg. Care., 25, No. 11, 791-796 (2009).
3. J. C. Hierholzer and R. A. Killington,Virology Methods Manual., Eds. B. W. J. Mahy and H. O. Kangro. London (1996).
4. National Research Council. Guide for the Care and Use of Laboratory Animals., 7th ed., Washington D.C. (1996).
5. S. M. Zimmer and D. S. Burke, N. Engl. J. Med., 361, 279-285 (2009).